Changzhou Qianhong Biopharma Co Ltd (002550) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Changzhou Qianhong Biopharma Co Ltd (002550) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥156.34 Million ≈ $22.88 Million USD) by net assets (CN¥2.76 Billion ≈ $403.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Changzhou Qianhong Biopharma Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Changzhou Qianhong Biopharma Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Changzhou Qianhong Biopharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002550 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Changzhou Qianhong Biopharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Changzhou Qianhong Biopharma Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nanjing Vazyme Biotech Co Ltd
SHG:688105
0.020x
Saha Pathana Inter-Holding PCL
BK:SPI
-0.003x
Nolato AB (publ)
ST:NOLA-B
0.038x
Pabrik Kertas Tjiwi Kimia Tbk
JK:TKIM
-0.011x
Chengdu Haoneng Tech Co Ltd
SHG:603809
0.000x
Westamerica Bancorporation
NASDAQ:WABC
0.032x
Pulse Biosciences Inc
NASDAQ:PLSE
-0.223x
UMH Properties Inc
NYSE:UMH
0.025x

Annual Cash Flow Conversion Efficiency for Changzhou Qianhong Biopharma Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Changzhou Qianhong Biopharma Co Ltd (002550) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.77 Billion
≈ $404.78 Million
CN¥361.36 Million
≈ $52.88 Million
0.131x -36.13%
2024-12-31 CN¥2.52 Billion
≈ $368.25 Million
CN¥514.71 Million
≈ $75.32 Million
0.205x -5.13%
2023-12-31 CN¥2.47 Billion
≈ $362.01 Million
CN¥533.33 Million
≈ $78.04 Million
0.216x +833.97%
2022-12-31 CN¥2.43 Billion
≈ $356.08 Million
CN¥-71.47 Million
≈ $-10.46 Million
-0.029x -160.08%
2021-12-31 CN¥2.12 Billion
≈ $309.95 Million
CN¥103.56 Million
≈ $15.15 Million
0.049x -68.17%
2020-12-31 CN¥2.07 Billion
≈ $302.24 Million
CN¥317.28 Million
≈ $46.43 Million
0.154x +121.81%
2019-12-31 CN¥2.33 Billion
≈ $341.34 Million
CN¥161.55 Million
≈ $23.64 Million
0.069x +590.82%
2018-12-31 CN¥2.54 Billion
≈ $371.42 Million
CN¥25.45 Million
≈ $3.72 Million
0.010x -72.22%
2017-12-31 CN¥2.45 Billion
≈ $358.94 Million
CN¥88.52 Million
≈ $12.95 Million
0.036x -60.41%
2016-12-31 CN¥2.42 Billion
≈ $354.79 Million
CN¥221.01 Million
≈ $32.34 Million
0.091x -27.00%
2015-12-31 CN¥2.29 Billion
≈ $335.75 Million
CN¥286.50 Million
≈ $41.92 Million
0.125x +5.67%
2014-12-31 CN¥2.13 Billion
≈ $312.08 Million
CN¥252.01 Million
≈ $36.88 Million
0.118x +45.10%
2013-12-31 CN¥1.97 Billion
≈ $288.35 Million
CN¥160.47 Million
≈ $23.48 Million
0.081x -23.84%
2012-12-31 CN¥1.87 Billion
≈ $273.47 Million
CN¥199.82 Million
≈ $29.24 Million
0.107x +28.62%
2011-12-31 CN¥1.77 Billion
≈ $258.44 Million
CN¥146.82 Million
≈ $21.48 Million
0.083x -79.94%
2010-12-31 CN¥413.78 Million
≈ $60.55 Million
CN¥171.51 Million
≈ $25.10 Million
0.415x +1109.63%
2009-12-31 CN¥243.68 Million
≈ $35.66 Million
CN¥8.35 Million
≈ $1.22 Million
0.034x -86.26%
2008-12-31 CN¥217.99 Million
≈ $31.90 Million
CN¥54.36 Million
≈ $7.95 Million
0.249x +46.60%
2007-12-31 CN¥211.61 Million
≈ $30.97 Million
CN¥35.99 Million
≈ $5.27 Million
0.170x --

About Changzhou Qianhong Biopharma Co Ltd

SHE:002550 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.30 Billion
CN¥8.91 Billion CNY
Market Cap Rank
#7682 Global
#1694 in China
Share Price
CN¥6.96
Change (1 day)
+2.50%
52-Week Range
CN¥5.78 - CN¥11.89
All Time High
CN¥12.27
About

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addit… Read more